Home›Companies›Biotech & Pharma›AponiaLabs

Aponia Laboratories Inc

Develops prescription and over-the-counter pain relief products for people with pain.

No LinkedIn page we could confirm. Why?
Updated Nov 9, 2026·Latest SEC filing Sep 24, 2026·Suggest an edit

About AponiaLabs

AponiaLabs is a private company based in Portsmouth, New Hampshire. It has reported $7,770,271 raised in eight offerings on Form D since July 2010. Its chief executive is Kenneth Corroon.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Not yetSep 24, 2026$0target not set0—EquityRule 506(b)Form D ↗
Apr 23, 2024May 8, 2024amended Apr 8, 2025$507,484fully sold2$253KDebtRule 506(b)Form D/A ↗1 earlier filing
Oct 12, 2021Oct 19, 2021$35,000fully sold1$35,000EquityRule 506(b)Form D ↗
Mar 26, 2015Mar 27, 2015$1,169,025of $3.7M target2$584KEquityRule 506(b)Form D ↗
Oct 14, 2014Oct 28, 2014$1,545,050of $3.8M target8$193KDebt, Convertible DebtRule 506(b)Form D ↗
Feb 20, 2012Mar 5, 2012$460,000of $1.7M target4$115KDebt, Options06Form D ↗
May 23, 2011Jun 6, 2011amended Jan 29, 2013$3,271,712of $6.5M target12$272KEquity06Form D/A ↗1 earlier filing
Jul 16, 2010Jul 29, 2010amended Jan 31, 2011$782,000of $1.0M target8$97,750Debt, Options06Form D/A ↗1 earlier filing
Total, eight offerings$7,770,271

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on AponiaLabs's Form D filed Sep 24, 2026.

Earlier filings also listed David McKane (director, last listed Apr 2025), Abhaya Jain (director, last listed Mar 2015) and Elizabeth Boolbol (executive officer, last listed Jan 2013).

Sources

  1. SECAponia Laboratories Inc Form D, filed May 8, 2024
  2. SECAponia Laboratories Inc Form D, filed Jun 6, 2011
  3. SECAponia Laboratories Inc Form D, filed Jul 29, 2010
  4. SECAponia Laboratories Inc filing history